Sarah Nikiforow

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.447Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry

Blood Advances(2025)10.1182/bloodadvances.2025015881

Top 42%

0.447DataRank

Top 42%18 citations

Kevin J. Curran, Erin Hall, Amy K. Keating, Susanne H.C. Baumeister, Sarah Nikiforow +15 more

Papers

Driven by 23 papers — median percentile 58. Top paper: “Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse”.

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse

Journal of Clinical Investigation(2022)10.1172/jci154334

N/A

3.2DataRank · unranked

139 citations

Grace C. Birch, Guangan Hu, Juliana Vergara Cadavid, Sarah Nikiforow, Joanna Baginska +27 more

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Blood(2020)10.1182/blood.2019004710

N/A

2.8DataRank · unranked

99 citations

Haesook T. Kim, Caitlin Costello, Alex F. Herrera, Frederick L. Locke, Rodrigo Maegawa +20 more

Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML

Blood Advances(2024)10.1182/bloodadvances.2023012120

N/A

1.2DataRank · unranked

46 citations

Haesook T. Kim, H. Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey Cutler +18 more

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

Blood(2020)10.1182/blood.2020006216

N/A

0.633DataRank · unranked

67 citations

Sarah Nikiforow, Michael K. Mansour, Zhen‐Huan Hu, Mary M. Horowitz, Marcie Riches +6 more

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Blood(2021)10.1182/blood.2021010867

N/A

0.564DataRank · unranked

42 citations

Yi Zhang, Alexandra Savell, Teddy Huang, Nicoletta Cieri, Emily M. Thrash +33 more

Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis

Blood(2020)10.1182/blood.2020008206

N/A

0.529DataRank · unranked

33 citations

Adam S. Sperling, Christopher J. Gibson, Kaushik Viswanathan, Cecilia A. Castellano, Marie McConkey +16 more

Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry

Blood Advances(2025)10.1182/bloodadvances.2025015881

Top 42%

0.447DataRank

Top 42%18 citations

Kevin J. Curran, Erin Hall, Amy K. Keating, Susanne H.C. Baumeister, Sarah Nikiforow +15 more

Donor clonal hematopoiesis and recipient outcomes after transplantation

medRxiv(2021)10.1101/2021.09.25.21263697

N/A

0.425DataRank · unranked

16 citations

Haesook T. Kim, Lin Zhao, H. Moses Murdock, Bryan C. Hambley, Alana F. Ogata +24 more

Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7552

N/A

0.396DataRank · unranked

13 citations

Frederick L. Locke, Zhen‐Huan Hu, Tanya Siddiqi, Sairah Ahmed, Armin Ghobadi +15 more

A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help

Blood Advances(2023)10.1182/bloodadvances.2023010401

N/A

0.385DataRank · unranked

12 citations

Sarah Nikiforow, Carlos Bachier, Yen‐Michael S. Hsu, David G. Maloney, Marcela V. Maus +9 more

Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.05.001

N/A

0.345DataRank · unranked

9 citations

Vincent T. Ho, Sarah Nikiforow, Corey Cutler, John Koreth, Roman M. Shapiro +7 more

Reduced incidence of relapse and graft-versus-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation

Haematologica(2025)10.3324/haematol.2025.287390

N/A

0.104DataRank · unranked

1 citations

Robert J. Soiffer, Corey Cutler, John Koreth, Sarah Nikiforow, Roman M. Shapiro +8 more

Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.029

N/A

0DataRank · unranked

10 citations

P. Connor Johnson, Haesook T. Kim, Alisha Yi, Meghan E. Sise, David E. Leaf +14 more

Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells

Blood Advances(2023)10.1182/bloodadvances.2022009231

N/A

0DataRank · unranked

12 citations

Haesook T. Kim, Heather Garrity, Deborah Liney, Corey Cutler, Joseph H. Antin +10 more

Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008735

N/A

0DataRank · unranked

79 citations

Omid Hamid, Krishna V. Komanduri, Rodabe N. Amaria, Marcus O. Butler, John B.A.G. Haanen +6 more

The utility of the novel optimized HLH inflammatory (OHI) index for predicting the risk for mortality and causes of death in lymphoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7570

N/A

0DataRank · unranked

0 citations

Jun Murakami, Liron Hofstetter, Uri Abadi, Swaminathan P. Iyer, Shehab Mohamed +15 more

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.006

N/A

0DataRank · unranked

312 citations

Tristan Knight, Kevin O. McNerney, Mark B. Leick, Tania Jain, Sairah Ahmed +26 more

ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.05.010

N/A

0DataRank · unranked

7 citations

Claire White, Magdi Elsallab, Stephanie Farnia, Ellen Fraint, Bambi Grilley +13 more

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

UNC Libraries(2024)10.17615/h0gs-sd07

N/A

0DataRank · unranked

1 citations

Michael K. Mansour, Zhen‐Huan Hu, Mary M. Horowitz, Peiman Hematti, Miguel‐Angel Perales +6 more

Comparative analysis of cell therapy infusion workflows at clinical sites

Cytotherapy(2021)10.1016/j.jcyt.2020.12.008

N/A

0DataRank · unranked

7 citations

Julianne Connors, Rachel Johnson, Elizabeth A. Van Orsow, David H. McKenna, Sarah Nikiforow +4 more

The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in patients with lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024014005

N/A

0DataRank · unranked

8 citations

Jun Murakami, Ronit Gurion, Swaminathan P. Iyer, Uri Abadi, Inbar Cohen +16 more

Poor Engraftment After Posttransplant Cyclophosphamide Graft‐Versus‐Host Disease Prophylaxis in Patients With Myelofibrosis

American Journal of Hematology(2025)10.1002/ajh.27741

N/A

0DataRank · unranked

3 citations

Deborah Liney, Kristen Rizza, Corey Cutler, John Koreth, Sarah Nikiforow +10 more

Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD

Blood Advances(2023)10.1182/bloodadvances.2023009791

N/A

0DataRank · unranked

24 citations

Vincent T. Ho, Eno Inyang, Corey Cutler, John Koreth, Roman M. Shapiro +9 more

Sarah Nikiforow

Indexed papers

Top data-sharing exemplar

Papers